Does the Addition of Involved Field Radiotherapy to High-Dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients With Relapsed/Refractory Hodgkin Lymphoma?

The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients

Rajesh Chopra, AK McMillan, DC Linch et al. · Blood · 1993 · 319 citations · Full text

Medicine, Hematology, Oncology +15

Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease

Alan R. Yuen, Saul A. Rosenberg, Richard T. Hoppe et al. · Blood · 1997 · 220 citations · Full text

Medicine, Immunology, Immunotherapy +10

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

DE Reece, JM Connors, JJ Spinelli et al. · Blood · 1994 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

Sundar Jagannath, Jamés O. Armitage, K. A. Dicke et al. · Journal of Clinical Oncology · 1989 · 210 citations

Medicine, Oncology, Radiation Oncology +14

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Donna Reece, Michael J. Barnett, J M Connors et al. · Journal of Clinical Oncology · 1991 · 176 citations

Medicine, Oncology, Pharmacology +16